91 related articles for article (PubMed ID: 667820)
1. Effect of progressive neoplastic growth on the decarboxylation of DL-[1-14C]ornithine by lymphocytes from C3H/He tumor hosts.
Vaage J; Agarwal S; Reinertsen JL
Cancer Res; 1978 Aug; 38(8):2253-8. PubMed ID: 667820
[TBL] [Abstract][Full Text] [Related]
2. Endogenous tumor growth factor indicated by increased ornithine decarboxylase activity in malignant cells treated with host serum ascites fluid.
Vaage J; Agarwal S
Cancer Res; 1979 May; 39(5):1511-7. PubMed ID: 427794
[TBL] [Abstract][Full Text] [Related]
3. Effects of retinoic acid and juvenile hormone on the induction of ornithine decarboxylase activity by 12-O-tetradecanoylphorbol-13-acetate.
Kensler TW; Verma AK; Boutwell RK; Mueller GC
Cancer Res; 1978 Sep; 38(9):2896-9. PubMed ID: 679197
[TBL] [Abstract][Full Text] [Related]
4. Suppressive factors in ascitic fluids and sera of mice bearing ascites tumors.
Elleman CJ; Eidinger D
J Natl Cancer Inst; 1977 Sep; 59(3):925-31. PubMed ID: 894749
[No Abstract] [Full Text] [Related]
5. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
Gordon WC; Prager MD
Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
[TBL] [Abstract][Full Text] [Related]
6. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody.
Luo JC; Toyoda M; Shibuya M
Cancer Res; 1998 Jun; 58(12):2594-600. PubMed ID: 9635584
[TBL] [Abstract][Full Text] [Related]
7. Halothane-induced suppression of cell-mediated immunity in normal and tumor-bearing C3Hf/He mice.
Lewis RE; Cruse JM; Hazelwood J
Anesth Analg; 1980 Sep; 59(9):666-71. PubMed ID: 7191225
[TBL] [Abstract][Full Text] [Related]
8. A factor responsible for increases in ornithine decarboxylase activity in the livers of tumor-bearing mice.
Noguchi T; Kashiwagi A; Tanaka T
Cancer Res; 1976 Nov; 36(11 Pt 1):4015-22. PubMed ID: 975047
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state.
Tada T; Ohzeki S; Utsumi K; Takiuchi H; Muramatsu M; Li XF; Shimizu J; Fujiwara H; Hamaoka T
J Immunol; 1991 Feb; 146(3):1077-82. PubMed ID: 1671050
[TBL] [Abstract][Full Text] [Related]
10. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo.
Gabizon A; Leibovich SJ; Goldman R
J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261
[TBL] [Abstract][Full Text] [Related]
11. Studies on different stages in host-tumor relationship. 1. Differences in the behavior in vitro of ascites cells and lymphocytes derived from mice in early and later stages of tumor growth.
Pikovski MA
Isr J Med Sci; 1973 Feb; 9(2):136-44. PubMed ID: 4696151
[No Abstract] [Full Text] [Related]
12. Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum.
Newberry WM; Sanford JP
J Clin Invest; 1971 Jun; 50(6):1262-71. PubMed ID: 5578233
[TBL] [Abstract][Full Text] [Related]
13. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
Strauss G; Gückel B; Wallwiener D; Moldenhauer G
Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
[TBL] [Abstract][Full Text] [Related]
14. [Ornithine decarboxylase activity in malignant tumors].
Siatkin SP; Berezov TT
Vopr Med Khim; 1980; 26(1):121-4. PubMed ID: 7368616
[TBL] [Abstract][Full Text] [Related]
15. Host endocrine responses during tumor growth.
Besedovsky H; del Rey A; Normann SJ
Prog Clin Biol Res; 1989; 288():203-13. PubMed ID: 2654951
[TBL] [Abstract][Full Text] [Related]
16. Protective serum effects in tumor immunity.
Vaage J
Isr J Med Sci; 1976; 12(4-5):334-43. PubMed ID: 939693
[TBL] [Abstract][Full Text] [Related]
17. Changes in the mitogen response of lymphoid cells with progressive tumor growth.
Gillette RW; Boone CW
Cancer Res; 1975 Dec; 35(12):3774-9. PubMed ID: 1081429
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of lymphocyte trapping by cell-free ascitic fluids cultivated in syngeneic mice.
Mongini PK; Rosenberg LT
J Immunol; 1975 Feb; 114(2 Pt 1):650-4. PubMed ID: 1120902
[TBL] [Abstract][Full Text] [Related]
19. Correlation of the inhibition by retinoids of tumor promoter-induced mouse epidermal ornithine decarboxylase activity and of skin tumor promotion.
Verma AK; Shapas BG; Rice HM; Boutwell RK
Cancer Res; 1979 Feb; 39(2 Pt 1):419-25. PubMed ID: 761215
[No Abstract] [Full Text] [Related]
20. Differential effect of interferon on DNA synthesis, 2-deoxyglucose uptake and ornithine decarboxylase activity in 3T3 cells stimulated by polypeptide growth factors and tumor promotors.
Sreevalsan T; Rozengurt E; Taylor-Papadimitriou J; Burchell J
J Cell Physiol; 1980 Jul; 104(1):1-9. PubMed ID: 6160162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
